Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam plus nitrous oxide sedation in hypertensive patients undergoing dental implant placement
RBR-7j4tgc6Phase 4Completed
- Sponsor
- Universidade de Santo Amaro
- Start
- Jun 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of midazolam, nitrous oxide and flumazenil in essential hypertension (2 arms), sponsored by Universidade de Santo Amaro. Started Jun 2025; status: completed.
02
Drugs
midazolamnitrous oxideflumazenil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on RBR-7j4tgc6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7j4tgc6.